NORCROSS, Ga.--(BUSINESS WIRE)--Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced its operating results for the quarter and six months ended June 30, 2012. Revenue for the second quarter of 2012 was $915,000, compared to $913,000 in the second quarter of 2011. Revenue for the first six months of 2012 was $1.6 million, compared to $1.7 million for the first six months of 2011. The variability in revenue was primarily due to the timing of receipts accrued under the Company’s contract with Konica Minolta. The company also reported sales revenue of $29,000 on the sale of two LuViva® Advanced Cervical Scan demonstration units in the second quarter.
